Month: May 2020

CALGARY, Alberta, May 28, 2020 (GLOBE NEWSWIRE) — Inventronics Limited (“Inventronics” or the “Corporation”) (IVX:TSX Venture), a designer and manufacturer of custom enclosures for the telecommunications, electric transmission, cable television and other industries in North America, today announced its unaudited 2020 Q1 financial results.For the three months ended March 31, 2020, Inventronics reported a net income of $44,000, or 1.0 cents per share, on revenue of $1,044,000 compared to net income of $20,000, or 0.5 cents per share, on revenue of $1,132,000 for the three months ended March 31, 2019. Further information about the financial results of the Corporation can be found in the Corporation’s unaudited interim financial statements for the quarter ended March 31, 2020 and accompanying management’s discussion and...

Les résultats de l’étude de prolongation ouverte (EPO) de l’essai pivot NEURO-TTR publiés dans la revue European Journal of Neurology montrent que les patients traités avec le TEGSEDI® (inotersen) ont bénéficié d’améliorations durables des mesures de l’évolution neuropathique après 39 mois de traitement et d’améliorations cliniquement pertinentes des mesures de la qualité de vie par rapport à l’évolution naturelle de la maladieAucun nouveau signal d’innocuité n’a été identifiéLe TEGSEDI se présente sous forme d’une injection sous-cutanée administrée au domicile du patientBOSTON et CARLSBAD, Californie, 28 mai 2020 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ : AKCA), une filiale à participation majoritaire d’Ionis Pharmaceuticals, Inc., et Ionis Pharmaceuticals,...

Im European Journal of Neurology veröffentlichte Ergebnisse aus der laufenden offenen Verlängerungsstudie (open-label extension, OLE) der zulassungsrelevanten Studie NEURO-TTR belegen, dass die mit TEGSEDI® (Inotersen) behandelten Patienten nach 39 Behandlungsmonaten eine nachhaltige Verbesserung des neuropathischen Krankheitsverlaufs und eine klinisch relevante Verbesserung der Lebensqualitätsparameter gegenüber dem natürlichen Verlauf der Erkrankung aufwiesenEs wurden keine neuen Sicherheitssignale festgestelltTEGSEDI ist eine subkutane Injektion, die zu Hause verabreicht wirdBOSTON und CARLSBAD, Kalifornien, May 28, 2020 (GLOBE NEWSWIRE) — Akcea Therapeutics, Inc. (NASDAQ: AKCA), eine Tochtergesellschaft im Mehrheitsbesitz von Ionis Pharmaceuticals, Inc., und Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) gaben heute die Veröffentlichung...

NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, announced today it has successfully completed an amendment to its senior, secured credit agreement.  The Company is a party to a syndicated credit facility comprised of an $800 million revolving line of credit and an $800 million amortizing term loan, both of which mature on September 1, 2022.  On March 24, 2020, as a precautionary measure, the Company elected to fully draw on its remaining revolving line of credit adding approximately $300 million of capacity to its balance sheet.  As of April 30, 2020, the Company had in excess of $500 million on its balance sheet. The amendment is expected to enhance financial flexibility as the Company continues to navigate the COVID-19 pandemic, in addition to addressing a scheduled stepdown...

The revised agreement announced in December 2019 is amended to address additional FTC areas of competitive concern primarily related to production for Sparkling Wine.Constellation’s Mission Bell facility is excluded from the transaction in response to concerns related to the production of the brands excluded from the December 2019 revised agreement.The transaction price is revised to approximately $1.03 billion, of which $250 million is an earnout based on divested brand performance over a two-year period.The transaction is expected to close in the second quarter of fiscal 2021, subject to FTC review.VICTOR, N.Y., May 28, 2020 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ and STZ.B), a leading beverage alcohol company, announced today that it and E. & J. Gallo Winery have further revised their original transaction...

Revenues up 36% to $10.4 million; Adjusted EBITDA up 21% to $1.8 millionBEVERLY, Mass. and TORONTO, May 28, 2020 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results for the quarter-ended March 31, 2020.HighlightsSales in USD increased 36% year over year to $10.4 million; sales in constant currency were up 38%Gross profit increased 31% year over year to $5.2 millionNet income increased $710 thousand to $145 thousandAdjusted EBITDA increased 21% year over year to $1.8 millionOrganic growth in USD was 11% for the quarter; 12% in constant currencyCash flow from operations was $709 thousand for the quarter; total cash at March...

BATON ROUGE, La., May 28, 2020 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED), one of America’s leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer will present at the 2020 Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020.The presentation will begin at 11:00 a.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.About Amedisys:Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering...

FLORHAM PARK, N.J., May 28, 2020 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a late clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that Terrie Curran, President and Chief Executive Officer and Azmi Nabulsi, M.D., Chief Operating Officer, will present at three upcoming virtual investor conferences in June, including:Jefferies Virtual Healthcare ConferenceDate: June 3, 2020Time: 3:30 pm EDTGoldman Sachs 41st Annual Global Healthcare Conference Date: June 11, 2020Time: 2:10 pm EDTBMO Prescriptions for Success Healthcare ConferenceDate: June 23, 2020Time: 4:00 pm EDTExecutive management will also participate in one-on-one meetings during the conferences.To access the live webcast and archived recordings for each presentation,...

VANCOUVER, British Columbia, May 28, 2020 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport Fuel Systems” or the “Company”) (TSX:WPRT / Nasdaq:WPRT) today announced that they have secured a €5 million loan from UniCredit Italia (“UniCredit”) to bolster liquidity during the COVID-19 pandemic.The loan, guaranteed by the Central Guarantee Fund for 90% of its countervalue has a five-year term, in accordance with Article 13 of the liquidity decree. This transaction and the earlier announced deferral of 2020 principal payments of US$6.0 million to Export Development Canada on March 25, 2020 confirms the Company’s strategy to secure and protect liquidity and to fund its operations through a prudent balance sheet policy.“The loan from UniCredit enables us to focus on the safe and efficient ramp-up of our Italian operations in Brescia...

MIAMI, May 28, 2020 (GLOBE NEWSWIRE) — NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“NCLH”, or the “Company”), announced today that it closed its previously announced private placement of $400 million in aggregate principal amount of its exchangeable senior notes due 2026 (the “Private Exchangeable Notes”) to an affiliate of L Catterton. NCLC expects to use the net proceeds from the placement of the Private Exchangeable Notes for general corporate purposes.The Private Exchangeable Notes will be general senior unsecured obligations of NCLC, guaranteed by NCLH, and will be exchangeable at the holder’s option at any time prior to the close of business on the business day immediately preceding the maturity date into Series A Preference Shares of NCLC, which shall be automatically exchangeable...